COVID-19 UPDATE Facts & Figures

In Short

A study in the New England Journal of Medicine found that Pfizer was 88% effective at preventing symptomatic disease from the Delta variant with both doses, compared with 93.7% against the Alpha variant. US borders with Mexico and Canada will remain closed to non-essential travel for another month.

Highlights:

  • July 21: 519,305 7-day average new cases, compared to 469,659 a week ago and 359,136 a month ago. Now confirmed 191,874,794 cases worldwide vs 188,239,660 cases last week.
  • 4,126,076 people have died (2.2% of confirmed cases) and 173,603,030 have recovered (90.5%).
  • Europe: 51,683,116 cases; 7-day avg growth of 124,876 vs 91,786 a week ago and 31,173 a month ago.
  • USA: 34,226,806 cases; 7-day avg growth of 39,939 vs 25,255 a week ago and 11,363 a month ago.
  • Vaccines: around 3.73 billion doses have been administered globally, of which 338 million in the USA and 436 million in the EU. 109 vaccines are in clinical evaluation and 184 vaccines are in preclinical evaluation.

Download the full publication below

COVID-19 UPDATE: Facts & Figures 22/07/2021
PDF
Picture

© Generali Investments, all rights reserved. This website is provided by Generali Investments and is considered as a marketing communication and financial promotion related to the products and services of the following companies belonging to the Generali group: Generali Asset Management S.p.A. Società di gestione del risparmio and Generali Investments Luxembourg S.A. (hereinafter jointly, Generali Investments). Moreover, the website may contain marketing communication and financial promotion of products and services of companies part of the multi-boutique platform coordinated by Generali Asset Management S.p.A. Società di gestione del risparmio and in particular of Infranity, Sycomore Asset Management, Aperture Investors LLC., Plenisfer Investments SGR, Lumyna Investments, Sosteneo Infrastructure Partners SGR and Generali Real Estate S.p.A. Società di Gestione del Risparmio